Rapid COJEC vs standard induction therapies
Event‐free survival · patients with high‐risk neuroblastoma
Rapid COJEC showed no clear difference in event‐free survival compared with standard induction therapies (low certainty).
1 finding from 1 review
- Rapid COJEC versus standard induction therapies for high‐risk neuroblastoma 2015 · Cochrane Headline outcomes onlyHR 0.86 [0.65, 1.13]1 study · 262 participantsLow